Mind Medicine (MindMed) Inc. (MNMD)
USD 7.23
(-3.41%)
USD 7.23
(-3.41%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -64.36 Million | -50.13 Million | -45.82 Million | -23.59 Million | -208.11 Thousand | -722.45 Thousand |
| Net Income | -95.73 Million | -56.79 Million | -93.03 Million | -33.93 Million | -1.11 Million | -857.94 Thousand |
| Depreciation & Amortization | 3.16 Million | 3.18 Million | 2.61 Million | - | 6683.69 | 6681.56 |
| Deferred income taxes | -2.02 Million | - | -1.15 Million | - | - | - |
| Stock-based compensation | 15.49 Million | 13.7 Million | 42.71 Million | 7.4 Million | - | - |
| Change in working capital | 6.28 Million | -3.78 Million | 1.88 Million | 2.06 Million | 207.82 Thousand | -20.46 Thousand |
| Other non-cash items | 8.45 Million | -6.44 Million | 1.15 Million | 873 Thousand | 703.52 Thousand | 160.96 Thousand |
| Investing Cash Flow | - | - | -297 Thousand | - | -213.15 Thousand | 541.33 Thousand |
| Investments in PPE | - | - | - | - | -313.45 Thousand | -1.04 Million |
| Acquisitions | - | - | -297 Thousand | - | - | - |
| Investment purchases | - | - | - | - | - | -70.11 Thousand |
| Sales/Maturities of investments | - | - | - | - | - | 1.65 Million |
| Other Investing Activities | - | - | - | - | 100.3 Thousand | - |
| Financing Cash Flow | 21.84 Million | 59.05 Million | 98.82 Million | 96.7 Million | 288.36 Thousand | 312.05 Thousand |
| Debt repayment | -14.15 Million | - | - | - | - | -15.44 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 7.69 Million | 42.29 Million | 81.92 Million | 71.99 Million | 288.36 Thousand | 327.49 Thousand |
| Other Financing Activities | 28.31 Million | 16.75 Million | 16.9 Million | 24.71 Million | - | - |
| Accounts receivables | - | - | - | -13 Thousand | 3018.56 | 1676.46 |
| Accounts payables | 2.02 Million | -2.05 Million | 1.28 Million | 544 Thousand | - | - |
| Inventory | - | - | - | 13 Thousand | - | - |
| Other working capital | 4.25 Million | -1.72 Million | 598 Thousand | 1.51 Million | 204.8 Thousand | -22.14 Thousand |
| Cash at beginning of period | 142.14 Million | 133.53 Million | 80.09 Million | 6.7 Million | 154.79 Thousand | 3977.67 |
| Cash at end of period | 99.7 Million | 142.14 Million | 133.53 Million | 80.09 Million | 17.93 Thousand | 154.79 Thousand |
| Capital Expenditure | - | - | - | - | -313.45 Thousand | -1.04 Million |
| Effect of forex changes on cash | 79 Thousand | -309 Thousand | 742 Thousand | 284 Thousand | -3951.00 | - |
| Net cash flow / Change in cash | -42.43 Million | 8.6 Million | 53.44 Million | 73.39 Million | -136.86 Thousand | 150.81 Thousand |
| Free Cash Flow | -64.36 Million | -50.13 Million | -45.82 Million | -23.59 Million | -521.57 Thousand | -1.76 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -5.85 Million | -54.4 Million | -23.86 Million | -95.73 Million | -17.92 Million | -29.13 Million |
| Depreciation & Amortization | - | 527 Thousand | 790 Thousand | 3.16 Million | 791 Thousand | 790 Thousand |
| Deferred income taxes | - | - | -5.25 Million | -2.02 Million | -2.68 Million | 1.16 Million |
| Stock-based compensation | 5.22 Million | 4.47 Million | 3.67 Million | 15.49 Million | 4.22 Million | 3.84 Million |
| Change in working capital | -3.42 Million | -677 Thousand | -3.89 Million | 6.28 Million | -1.13 Million | 9.47 Million |
| Other non-cash items | -10.45 Million | 39 Million | 8.75 Million | 8.45 Million | 100 Thousand | 14 Thousand |
| Investing Cash Flow | - | - | -487.98 Thousand | - | 359 Thousand | - |
| Investments in PPE | 2.39 | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | -359 Thousand | - | - | - |
| Financing Cash Flow | 9.51 Million | 169.24 Million | 2.31 Million | 21.84 Million | 17.39 Million | 1.27 Million |
| Debt repayment | -9.8 Million | -128 Thousand | -229.81 Thousand | -14.15 Million | -14.25 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | -416.58 Thousand | 169.42 Million | 2.54 Million | 7.69 Million | 3.08 Million | 1.27 Million |
| Other Financing Activities | 382.15 | -54 Thousand | 21.79 Million | 28.31 Million | 28.56 Million | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -2.96 Million | 1.5 Million | -3.51 Million | 2.02 Million | -931 Thousand | 6.25 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -3.42 Million | -677 Thousand | -385.21 Thousand | 4.25 Million | -207 Thousand | 3.21 Million |
| Cash at beginning of period | 252.33 Million | 99.7 Million | 117.69 Million | 142.14 Million | 116.89 Million | 129.4 Million |
| Cash at end of period | 243.13 Million | 252.33 Million | 99.7 Million | 99.7 Million | 117.69 Million | 116.89 Million |
| Capital Expenditure | 2.39 | - | - | - | - | - |
| Effect of forex changes on cash | 1000.00 | -21 Thousand | -25 Thousand | 79 Thousand | 32 Thousand | 57 Thousand |
| Net cash flow / Change in cash | -9.2 Million | 152.62 Million | -17.99 Million | -42.43 Million | 804 Thousand | -12.51 Million |
| Free Cash Flow | -19.73 Million | -16.59 Million | -19.79 Million | -64.36 Million | -16.62 Million | -13.84 Million |
VEV
SIE
KTCG
9362
2230
SEQUA